tirzepatide use in pregnancy safety and Zepbound and Pregnancy: Risks, Breastfeeding,

Acne symptoms decreased and there was a reduction in the occurrence of cysts and pain associated with cystic acne and improvements in short term memory

Clear labelling: All reconstituted products must be clearly labelled with the drug name, concentration, preparation date/time, beyond-use date, and preparer's identification

Clinical trials assessing the effects of GH treatment in patients with obesity have shown consistent reductions in total adipose tissue mass, in particular abdominal and visceral adipose tissue depots

The minimal differences in genetic effect estimates (Beta difference range: 0.001-0.003) between female and sex-combined data for the exposure-mediator relationships indicate that sex is not a major effect modifier at this step, validating the use of sex-combined data for these mediators in our primary analysis